NEW YORK (GenomeWeb) – Olink AB announced today that it has completed a reorganization and has split into two separate companies — Olink Proteomics and Olink Bioscience.

Olink Proteomics will continue to expand and develop the Proseek Multiplex human protein biomarker discovery product portfolio and is aiming to create a variety of high-quality multiplex immunoassays for biomarker discovery as well as diagnostic tools based on clinically relevant protein signatures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.